PL
FMTX

Parkwood LLC’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Parkwood LLC’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-36,555
Closed -$520K – 152
2021
Q4 		$520K Buy
36,555
+7,210
+25% +$125K 0.09% 93
2021
Q3 		$681K Buy
29,345
+4,217
+17% +$99.7K 0.08% 96
2021
Q2 		$625K Buy
25,128
+1,047
+4% +$28.1K 0.07% 105
2021
Q1 		$675K Sell
24,081
-20,117
-46% -$726K 0.12% 85
2020
Q4 		$1.54M Buy
+44,198
New +$1.92M 0.19% 80

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parkwood LLC's FMTX Position: Q1 2022 in Review

Parkwood LLC sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q1 2022, closing a stake of 36,555 shares — an estimated $520K sold.

Parkwood LLC first reported a position in FMTX in Q4 2020 and held it in 5 quarters. The position peaked at $1.54M in Q4 2020. 98 funds tracked by Wall St. Rank hold FMTX as of Q1 2022.

  • Parkwood LLC reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Parkwood LLC sold 36,555 Forma Therapeutics Holdings, Inc. Common Stock shares in Q1 2022, an estimated $520K.
  • Parkwood LLC first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Parkwood LLC's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.54M in Q4 2020.
  • 98 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q1 2022.

Based on Parkwood LLC's 13F filing for Q1 2022, filed 13 May 2022.